Status:

TERMINATED

Aldosterone Antagonism and Microvascular Function

Lead Sponsor:

Maastricht University Medical Center

Conditions:

Abdominal Obesity Metabolic Syndrome

Insulin Resistance

Eligibility:

All Genders

40-65 years

Phase:

PHASE4

Brief Summary

The prevalence of obesity and obesity-related complications is currently taking epidemic proportions. These complications increase the risk of type 2 diabetes and cardiovascular disease, which are imp...

Eligibility Criteria

Inclusion

  • Age 40-65 years
  • Caucasian
  • Waist circumference \> 102 cm (men)/\> 88 cm (women)
  • Triglycerides \> 1.7 mmol/L
  • High-normal blood pressure (office blood pressure: 130/85 - 139/89 mm Hg) or stage I hypertension (office blood pressure: 140/90 mm Hg - 159/99 mm Hg; 24h ABPM: 125/80 - 149/89 mm Hg)

Exclusion

  • Cardiovascular disease (stroke, coronary artery disease, peripheral vascular disease, congestive heart failure, cardiac shunts, cardiac surgery, pulmonary hypertension, cardiac arrhythmias, family history of cardiac arrhythmias or sudden cardiac death)
  • Diabetes mellitus/impaired glucose metabolism (fasting glucose values \> 5.6 mmol/L)
  • Grade 2 or 3 hypertension (office blood pressure: \> 160/100 mm Hg; ABPM \> 150/90 mm Hg)
  • Unstable or severe pulmonary disease
  • Unstable or severe thyroid disorders
  • Inflammatory diseases
  • Alcohol use \> 2 U/day (women)/\> 3 U/day (men)
  • Use of antihypertensive, lipid-lowering or glucose-lowering medications,
  • Use of corticosteroids, medication known to inhibit or induce CYP3A4, lithium, and tricyclic antidepressants or antipsychotic medication, and regular use (weekly or several times a week) of NSAIDs
  • Plasma potassium levels \< 3.2 mmol/L or \> 5 mmol/L
  • eGFR \< 60 mL/min
  • Impairment of hepatic function
  • Pregnancy or lactation

Key Trial Info

Start Date :

October 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2018

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT01887119

Start Date

October 1 2013

End Date

November 1 2018

Last Update

November 5 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Maastricht University

Maastricht, Limburg, Netherlands, 6229 ER